Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer
- Type
- Retraction
- Notice date
- 11/6/2023 0:00
- Journal
- Experimental and Therapeutic Medicine
- Publisher
- Spandidos
- Notice DOI
- 10.3892/etm.2023.12288
- Original paper DOI
- 10.3892/etm.2021.10624